Reagent will be used for the immunotoxin project in DR pastan's group
Ended Purchase Order Awarded
- Contract number
- 75N91021P00509
- Awardee
-
Kerafast Inc. UEI UPZ8NTQMGXB6 Part of Absolute Antibody LIMITED
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $15,650
Award facts
- Contract value 100% obligated
- $15,650.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Boston, MA 02210, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N91021P00509?
75N91021P00509 was awarded to Kerafast Inc. by National Cancer Institute (National Institutes of Health) on June 3, 2021.
How much is contract 75N91021P00509 worth?
The government has obligated $15,650 on 75N91021P00509.
Was contract 75N91021P00509 competed?
The extent of competition for 75N91021P00509 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award